Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
- PMID: 17712758
- PMCID: PMC4142488
- DOI: 10.1086/520989
Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
Abstract
Occult hepatitis B virus (HBV) infection is of concern in human immunodeficiency virus (HIV)-infected persons. We observed that 2% of 400 HIV-infected women with antibodies to hepatitis B core antigen alone had occult HBV infection (i.e., detectable HBV DNA in the absence of HBV surface antigen). CD4 cell counts of <200 cells/mm3 were more common among occult HBV-infected women than among those without occult HBV infection. Aminotransferase levels did not appear to be associated with being positive for HBV DNA.
Conflict of interest statement
Figures

Similar articles
-
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.J Med Virol. 2007 Oct;79(10):1464-71. doi: 10.1002/jmv.20954. J Med Virol. 2007. PMID: 17705185
-
[Investigation of occult hepatitis B in HIV infected patients].Mikrobiyol Bul. 2011 Apr;45(2):353-8. Mikrobiyol Bul. 2011. PMID: 21644079 Turkish.
-
Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.Int J STD AIDS. 2008 Mar;19(3):197-9. doi: 10.1258/ijsa.2007.007200. Int J STD AIDS. 2008. PMID: 18397562
-
The role of anti-core antibody response in the detection of occult hepatitis B virus infection.Clin Chem Lab Med. 2010;48(1):23-9. doi: 10.1515/CCLM.2010.002. Clin Chem Lab Med. 2010. PMID: 19919328 Review.
-
Functional Cure of Hepatitis B Virus Infection in Individuals With HIV-Coinfection: A Literature Review.Viruses. 2021 Jul 11;13(7):1341. doi: 10.3390/v13071341. Viruses. 2021. PMID: 34372547 Free PMC article. Review.
Cited by
-
Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):274-80. doi: 10.1097/QAI.0000000000000969. J Acquir Immune Defic Syndr. 2016. PMID: 26918547 Free PMC article.
-
Prevalence of occult hepatitis B among HIV-positive individuals in Africa: A systematic review and meta-analysis.SAGE Open Med. 2022 Jan 30;10:20503121211072748. doi: 10.1177/20503121211072748. eCollection 2022. SAGE Open Med. 2022. PMID: 35127096 Free PMC article.
-
Isolated Anti-HBc: Significance and Management.J Clin Med. 2020 Jan 11;9(1):202. doi: 10.3390/jcm9010202. J Clin Med. 2020. PMID: 31940817 Free PMC article. Review.
-
Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women.Clin Infect Dis. 2009 Jul 1;49(1):148-54. doi: 10.1086/599610. Clin Infect Dis. 2009. PMID: 19480573 Free PMC article.
-
Reappraisal of screening strategy in hepatitis B surface antigen-negative blood donors: Correlation with hepatitis B virus-DNA quantification.Asian J Transfus Sci. 2022 Jan-Jun;16(1):89-94. doi: 10.4103/ajts.AJTS_157_18. Epub 2022 May 26. Asian J Transfus Sci. 2022. PMID: 36199415 Free PMC article.
References
-
- Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2:479–486. - PubMed
-
- Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998;17:6–13. - PubMed
-
- Neau D, Winnock M, Galperine T, et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med. 2004;5:171–173. - PubMed
-
- Barkan SE, Melnick SL, Preston-Martin S, et al. The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117–125. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR000079/RR/NCRR NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- P30 DK26743/DK/NIDDK NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- M01-RR-00083/RR/NCRR NIH HHS/United States
- K23 AI066943/AI/NIAID NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- K23 AI 66943-01/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- M01-RR-00079/RR/NCRR NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- M01-RR-00071/RR/NCRR NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- K12 RR024140/RR/NCRR NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials